Università degli Studi di Perugia

Degree course in Pharmaceutical biotechnologies

Course Name
PHARMACEUTICAL BIOTECHNOLOGIES
Course Code
LM38
Class (Ministerial code)
LM-9
Website
https://www.dsf.unipg.it/didattica/cdlm/biotecnologie-farmaceutiche-lm-9-d-m-270-2004/1003-a-a-2020-2021-bf
Field(s) of study
ISCED Area 05 – Natural sciences, mathematics and statistics
Qualification award
Master Degree
Level of qualification according to the NQF and the EQF
EHEA Second cycle; EQF Level 7
Length of programme / number of credits
2 years / 120 ECTS
Language of Teaching
Italian
Mode of study
In class
Didactic centre
Polo didattico Via del Giochetto, Perugia
Programme director
Prof.ssa Francesca Fallarino
Access to the course
Open access with assessment of personal competences
Specific admission requirements
Formal Requirements Italian First cycle qualification (Laurea) or foreign equivalent in the same or related subject area, with possible extra work if required competences are lacking.
Evaluation of specific subject knowledge on entry
Verification of the possession of the curricular requirements with the methods indicated in the academic regulation of the course of study Foreign students are required to take a test to verify their proficiency of the Italian language, except Erasmus Incoming students, Exchange Students and students in mobility as per the Cooperation Agreement
Profile of the programme
The master's degree course provides an advanced and multidisciplinary theoretical and practical preparation in the pharmaceutical biotechnological field which, also starting from knowledge of pharmacogenetics and pharmacogenomics, leads to advanced aquired competencies in different fields of farmaceutical biotechnology. Thses include the production, experimentation, registration, and marketing of innovative drugs, such as macromolecules produced through biotechnological methods in public and private structures, as well as in academic research
Programme learning outcomes
In this master the students will acquire: • in-depth knowledge of different methods of DNA expression and genome analysis, using innovative and multidisciplinary tools, such as those necessary for functional analysis of the proteome; • knowledge and skills in basic and advanced biotechnology, required for the production of recombinant molecules, metabolic engineering and molecular modeling in the pharmaceutical field •knowledge and skills in the field of biomaterials and in issues connected with intellectual property and related to rules required for the organization and management of biotechnological companies; •Ability to use basic and more advanced bioinformatics methodologies and knowledge of the modalities of accessing to genomics, transcriptomics, proteomics and metabolomics, and structural databases.
Qualification requirements and regulations
To be admitted to the final test for the achievement of the master degree, the student must have acquired all the credits foreseen in the study plan related to the training activities. The final test for the achievement of the degree qualification is public and consists in the presentation of an experimental thesis work,l to a specific committee. This experimental work can be performed in luniversities or biotech companies research laboratories either national or foreign, that have set specific agreements with the university. The experimental work in areas related to pharmaceutical biotechnology, will be supervised by a professor or researcher teaching in the master either alone or in collaboration with others qualified Professors or reaserchers beloging to the same university or to other research laboratories both national or international, under specific agreements.
Examination regulations and grading scale
Assessment is normally an oral or written exam; in rare cases there are intermediate exams during the course; other evaluation elements (seminars, reports, etc.) can be foreseen in specific course units and are described in the Course Unit Profiles. The grades for the exams are measured in thirtieths (0-30 scale), the minimum grade is 18/30 and the maximum grade is 30/30. The maximum grade can be enhanced with “cum laude” (30 cum laude), in case of excellence. Grades are given by an exam commission of at least two teachers, whose President is the chair of the subject. The main exam sessions are held in January/February, March/April, June/July, September/October. Students may retake exams, if not passed. The University provides an ECTS Grading Table, which shows the actual distribution of the examination and final grades among students for each degree programme. The final degree evaluation is expressed in one hundred and tenths (0-110 scale), the minimum grade is 66/110 and the maximum grade is 110/110. The calculation of the final grade of each candidate takes into account the average of the grades obtained in the subject exams, as well as the quality of the work performed in research and the final thesis which is discussed in public before an exam commission. “Cum laude” (110 cum laude) may be added to the maximum grade if the exam commission decides unanimously.
Obligatory or optional mobility windows
The credits acquired by the student during a period of study abroad or during a virtual mobility are fully used for the achievement of the final degree, without any further activity or learning verification for the
Work-based learning
The internship is a training experience corresponding to 10 ECTS is very important as it allows the student to acquire further practical expertise in specific fields related to biotechnology, The internship, under the responsibility of an internal tutor from the master, can be carried out at one of the University laboratories, within the Erasmus program, or in another international mobility program. At the end of the internship, the student should prepare a short report on the work done, which will be presented to a specific commitee that will evaluate the training assigning the score "eligeble" if positive
Occupational profiles of graduates
Graduates will gain the specific expertise to work in various working contexts, such as research field (universities and public and private research institutes), in biotech companies, biotechnology sector and other companies interested in biotechnological innovation. Moreover, they can also teach in secondary schools.
UnitLanguageAnnoPeriodCFU
ADVANCED MOLECULAR BIOLOGY
In all curricula
Italian1I6
ADVANCED PHARMACEUTICAL CHEMISTRY
In all curricula
Italian1II6
APPLIED BIOLOGY AND BASIC AND MOLECULAR GENETICS OF BIODRUGS
In all curricula
Italian1I12
BIODRUGS IN CELLULAR AND ANIMAL ENGINEERING
In all curricula
Italian1II6
BIOMEDICAL TECHNOLOGY
In all curricula
Italian1I6
BIOORGANIC CHEMISTRY
In all curricula
Italian1II6
CHEMICAL AND FERMENTATIVE METHODOLOGIES FOR PRODUCTION OF BIODRUGS
In all curricula
Italian1II6
MOLECULAR PATHOLOGY
In all curricula
Italian1II6
NON-VIRAL VEHICLES FOR GENE THERAPY
In all curricula
Italian1I6
BIOMATERIALS: ADVANCED APPLICATIONS AND REGULATORY ISSUES
In all curricula
Italian2I8
ELECTIVE EXAM
In all curricula
2I6
ELECTIVE EXAM
In all curricula
2II6
PRACTICAL TRAINING APPLICATION
In all curricula
Italian2I10
RATIONAL DRUG DESIGN
In all curricula
Italian2I6

Free-choice training activities

UnitPeriodCFU
Group ATTIVITA' A SCELTA LIBERA STUDENTE
CFU (University training credits) required: Min1 - Max12
Condividi su
Visualizza la versione precedente del portale